Axaron Bioscience AG
🇩🇪Germany
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Treatment With AX200 for Acute Ischemic Stroke
Phase 2
Completed
- Conditions
- Cerebral Stroke
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2007-07-25
- Lead Sponsor
- Axaron Bioscience AG
- Target Recruit Count
- 42
- Registration Number
- NCT00132470
- Locations
- 🇩🇪
Neurology University of Heidelberg, Heidelberg, Germany
🇩🇪Neurology University of Muenster, Muenster, Germany
News
No news found